Baqsimi Powder
NDC Package 0548-8352-02

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Baqsimi (glucagon) powders is a medication the same as your body's own glucagon, a natural substance that raises blood sugar by causing the body to release sugar stored in the liver. This formulation utilizes a powder delivery system. Marketed by Amphastar Pharmaceuticals, Inc., this product is identified by NDC 0548-8352 and is authorized under FDA application NDA210134.

Identification & Billing

NDC Package Code
0548-8352-02
Package Description
2 TUBE in 1 CARTON / 1 BOTTLE, UNIT-DOSE in 1 TUBE / 1 POWDER in 1 BOTTLE, UNIT-DOSE
Product Code
0548-8352
11-Digit Billing Format
00548835202
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
2 EA
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Baqsimi
Non-Proprietary Name
Glucagon
Substance Name
Glucagon
Dosage Form
Powder - An intimate mixture of dry, finely divided drugs and/or chemicals that may be intended for internal or external use.
Administration Route
Nasal - Administration to the nose; administered by way of the nose.
Active Ingredient(s)
GLUCAGON 3 mg/1
Pharmacologic Class
Usage Information
This medication is the same as your body's own glucagon, a natural substance that raises blood sugar by causing the body to release sugar stored in the liver. It is used to treat very low blood sugar (hypoglycemia) that may cause you to need help from others. Make sure a family member or caregiver knows where you keep this medication and how to use it before you need their help.

Regulatory & Marketing

Labeler Name
Amphastar Pharmaceuticals, Inc.
Product Type
Human Prescription Drug
FDA Application #
NDA210134
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
07-24-2019
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0548-8352-02 identifies a specific commercial package of 2 tube in 1 carton / 1 bottle, unit-dose in 1 tube / 1 powder in 1 bottle, unit-dose of Baqsimi, a human prescription drug labeled by Amphastar Pharmaceuticals, Inc.. This powder is formulated for nasal use and contains glucagon as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Amphastar Pharmaceuticals, Inc. on July 24, 2019. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

This medication is the same as your body's own glucagon, a natural substance that raises blood sugar by causing the body to release sugar stored in the liver. It is used to treat very low blood sugar (hypoglycemia) that may cause you to need help from others. Make sure a family member or caregiver knows where you keep this medication and how to use it before you need their help.

How is this Amphastar Pharmaceuticals, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00548835202. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 2 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0548-8352-02
11-Digit CMS (5-4-2)
00548-8352-02

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.